Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
89.4M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
-917K
-
Total reported value, excl. options
-
$39.9M
-
Value change
-
-$1.77M
-
Put/Call ratio
-
0
-
Number of buys
-
11
-
Number of sells
-
-12
-
Price
-
$1.32
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q2 2024
48 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares as of Q2 2024.
Milestone Pharmaceuticals Inc. - Common Shares (MIST) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
of 89.4M outstanding shares and own 33.77% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.97M shares), RTW INVESTMENTS, LP (3.26M shares), MILLENNIUM MANAGEMENT LLC (2.75M shares), Alta Fundamental Advisers LLC (2.66M shares), Lion Point Capital, LP (2.34M shares), CITADEL ADVISORS LLC (2.15M shares), ORBIMED ADVISORS LLC (2M shares), Nantahala Capital Management, LLC (1.75M shares), GOLDMAN SACHS GROUP INC (1.35M shares), and Bleichroeder LP (1.33M shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.